MedTrace Logo

Dexamethasone as an Adjuvant in Supraclavicular Block

NCT04345588 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-04-14

No results posted yet for this study

Summary

The use of dexamethasone perineurally along with local anesthetic has been shown to improve the duration of analgesia .

Conditions

  • Dexamethasone Efficacy as an Adjuvant in Supraclavicular Block

Interventions

DRUG

Dexamethasone injection

we use injection lignocaine 10 mL, injection bupivacaine 0.5% 20 mL, 5 mL normal saline (NS). In group , injection dexamethasone 0.05 mg/kg will be added to the solution along with IV NS 1cc while the other group will receive 0.05 mg/kg injection dexamethasone intravenously.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Islam Mohamed Abdel Hamid, post graduated

  • Golinar Mohamed Fathy, professor

  • Ahmed Mohamed Abdel Moteleb, lecturer

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-01-01
Completion
2022-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04345588 on ClinicalTrials.gov